Insider Transactions last 24 months for Atea Pharmaceuticals, Inc.  -  NSDQ: AVIR

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Lucidi BrunoDirector06/20/2025AMDirectCOM29,600$0.00$0.00112,750
Polsky BruceDirector06/20/2025AMDirectCOM29,600$0.00$0.0095,206
Berger Franklin MDirector06/20/2025AMDirectCOM29,600$0.00$0.00506,497
Murphy Polly A.Director06/20/2025AMDirectCOM29,600$0.00$0.0086,045
Adams Jerome M.Director06/20/2025AMDirectCOM29,600$0.00$0.0062,750
Duncan Barbara GayleDirector06/20/2025AMDirectCOM29,600$0.00$0.0062,750
Foster WayneEVP, Chief Accounting Officer01/31/2025DFDirectCOM12,062$3.06$36,909.7250,128
Foster WayneEVP, Chief Accounting Officer01/31/2025AADirectCOM8,000$0.00$0.0062,190
Foster WayneEVP, Chief Accounting Officer01/31/2025AMDirectCOM33,333$0.00$0.0054,190
Sommadossi Jean-PierrePresident, CEO, and Chairman01/31/2025DFDirectCOM88,601$3.06$271,119.06300,940
Sommadossi Jean-PierrePresident, CEO, and Chairman01/31/2025AADirectCOM99,517$0.00$0.00389,541
Sommadossi Jean-PierrePresident, CEO, and Chairman01/31/2025AMDirectCOM173,467$0.00$0.00290,024
Corcoran AndreaSee Remarks01/31/2025DFDirectCOM16,102$3.06$49,272.12717,307
Corcoran AndreaSee Remarks01/31/2025AADirectCOM10,500$0.00$0.00733,409
Corcoran AndreaSee Remarks01/31/2025AMDirectCOM44,367$0.00$0.00722,909
Horga Maria ArantxaChief Medical Officer01/31/2025DFDirectCOM16,071$3.06$49,177.2660,876
Horga Maria ArantxaChief Medical Officer01/31/2025AADirectCOM9,750$0.00$0.0076,947
Horga Maria ArantxaChief Medical Officer01/31/2025AMDirectCOM41,533$0.00$0.0067,197
Vavricka JohnChief Commercial Officer01/31/2025DFDirectCOM11,517$3.06$35,242.0252,081
Vavricka JohnChief Commercial Officer01/31/2025AADirectCOM8,750$0.00$0.0063,598
Vavricka JohnChief Commercial Officer01/31/2025AMDirectCOM33,333$0.00$0.0054,848
Hammond Janet MjChief Development Officer01/31/2025DFDirectCOM14,134$3.06$43,250.0481,388
Hammond Janet MjChief Development Officer01/31/2025AADirectCOM11,250$0.00$0.0095,522
Hammond Janet MjChief Development Officer01/31/2025AMDirectCOM46,800$0.00$0.0084,272
Berger Franklin MDirector01/16/2025DPDirectCOM10,000$3.36$33,614.00476,897
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel